Institutional Ownership C4 Therapeutics, Inc. (CCCC)
This table provides information about the institutional ownership of C4 Therapeutics, Inc. (CCCC). We have compiled data on the 117 institutions that hold shares in the stock, with a total of 63.1 Million shares, which have been reported (via 13F filing form) to have a value of $94 Million.
Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
---|---|---|---|---|---|
Lynx1 Capital Management LP
San Juan, PR |
May 15, 2025 Q1 2025 |
7,098,133
shares
|
$10.6 Million
4.2% of portfolio
|
Q1 2025
Added 3.58%
|
|
Soleus Capital Management, L.P.
Greenwich, CT |
May 15, 2025 Q1 2025 |
6,978,942
shares
|
$10.4 Million
0.92% of portfolio
|
Q4 2024
Added 5.68%
|
|
Orbimed Advisors LLC
San Diego, CA |
May 15, 2025 Q1 2025 |
6,830,300
shares
|
$10.2 Million
0.34% of portfolio
|
Q1 2025
Added 56.02%
|
|
Wasatch Advisors Inc
Salt Lake City, UT |
May 15, 2025 Q1 2025 |
6,724,409
shares
|
$10 Million
0.06% of portfolio
|
Q1 2025
Added 10.73%
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
4,551,510
shares
|
$6.78 Million
0.0% of portfolio
|
Q2 2024
Added 402.93%
|
|
Morgan Stanley
New York, NY |
May 15, 2025 Q1 2025 |
4,045,329
shares
|
$6.03 Million
0.0% of portfolio
|
Q1 2025
Added 5.36%
|
|
Vanguard Group Inc
Valley Forge, PA |
May 09, 2025 Q1 2025 |
3,370,880
shares
|
$5.02 Million
0.0% of portfolio
|
Q1 2025
Added 0.74%
|
|
Samlyn Capital, LLC
New York, NY |
May 15, 2025 Q1 2025 |
3,015,139
shares
|
$4.49 Million
0.08% of portfolio
|
Q1 2025
Reduced 0.14%
|
|
Bank Of America Corp
Charlotte, NC |
May 15, 2025 Q1 2025 |
1,990,824
shares
|
$2.97 Million
0.0% of portfolio
|
Q1 2025
Added 18.67%
|
|
Adage Capital Partners Gp, L.L.C.
Boston, MA |
May 15, 2025 Q1 2025 |
1,550,000
shares
|
$2.31 Million
0.0% of portfolio
|
Q4 2024
Added 198.08%
|
|
Geode Capital Management, LLC
Boston, MA |
May 13, 2025 Q1 2025 |
1,430,288
shares
|
$2.13 Million
0.0% of portfolio
|
Q1 2025
Added 3.56%
|
|
Arrow Mark Colorado Holdings LLC
Denver, CO |
May 15, 2025 Q1 2025 |
1,286,712
shares
|
$1.92 Million
0.04% of portfolio
|
Q1 2025
Reduced 3.55%
|
|
State Street Corp
Boston, MA |
May 15, 2025 Q1 2025 |
1,224,418
shares
|
$1.82 Million
0.0% of portfolio
|
Q1 2025
Added 0.11%
|
|
Bain Capital Life Sciences Investors, LLC
Boston, MA |
May 15, 2025 Q1 2025 |
1,111,910
shares
|
$1.66 Million
0.6% of portfolio
|
Q2 2024
Reduced 2.65%
|
|
Tang Capital Management LLC
San Diego, CA |
May 15, 2025 Q1 2025 |
900,000
shares
|
$1.34 Million
0.09% of portfolio
|
Q4 2024
Added 28.57%
|
|
Silverarc Capital Management, LLC
|
May 14, 2025 Q1 2025 |
882,300
shares
|
$1.31 Million
0.34% of portfolio
|
Q1 2025
Reduced 27.75%
|
|
Ubs Group Ag
|
May 13, 2025 Q1 2025 |
872,770
shares
|
$1.3 Million
0.0% of portfolio
|
Q1 2025
Added 15.16%
|
|
David A. Siegel
Two Sigma Advisers, LP | New York, Ny
|
May 15, 2025 Q1 2025 |
800,600
shares
|
$1.19 Million
0.0% of portfolio
|
Q1 2025
Reduced 9.47%
|
|
Jacobs Levy Equity Management, Inc
Florham Park, NJ |
May 15, 2025 Q1 2025 |
697,653
shares
|
$1.04 Million
0.0% of portfolio
|
Q1 2025
New holding
|
|
Goldman Sachs Group Inc
New York, NY |
May 16, 2025 Q1 2025 |
622,720
shares
|
$927,852
0.0% of portfolio
|
Q1 2025
Added 8.55%
|
|
Wells Fargo & Company
San Francisco, CA |
May 13, 2025 Q1 2025 |
523,619
shares
|
$780,192
0.0% of portfolio
|
Q1 2025
Added 1342.24%
|
|
Two Sigma Investments, LP
New York, NY |
May 15, 2025 Q1 2025 |
514,603
shares
|
$766,758
0.0% of portfolio
|
Q1 2025
Reduced 8.73%
|
|
Dimensional Fund Advisors LP
Austin, TX |
May 13, 2025 Q1 2025 |
514,155
shares
|
$766,090
0.0% of portfolio
|
Q1 2025
Reduced 1.87%
|
|
Northern Trust Corp
Chicago, IL |
May 13, 2025 Q1 2025 |
499,768
shares
|
$744,654
0.0% of portfolio
|
Q1 2025
Added 0.95%
|
|
Charles Schwab Investment Management Inc
San Francisco, CA |
May 09, 2025 Q1 2025 |
474,843
shares
|
$707,516
0.0% of portfolio
|
Q1 2025
Reduced 2.37%
|